Pascal, A. et al. Neurodevelopmental outcome in very preterm and very-low-birthweight infants born over the past decade: a meta-analytic review. Dev. Med. Child Neurol. 60, 342–355 (2018).
Tita, A. T. N. & Andrews, W. W. Diagnosis and management of clinical chorioamnionitis. Clin. Perinatol. 37, 339–354 (2010).
Anblagan, D. et al. Association between preterm brain injury aand exposure to chorioamnionitis during fetal life. Scientific Rep. 6 (2016).
McDonald, C. A. et al. in Umbilical Cord Blood Banking for Clinical Application and Regenerative Medicine (2017).
Novak, I. et al. Concise review: stem cells interventions for people with cerebral palsy: systematic review with meta-analysis. Stem Cells Transl. Med. 5, 1014–1025 (2016).
Paton, M. C. B. et al. Perinatal brain injury as a consequence of preterm birth and intrauterine inflammation: designing targeted stem cell therapies. Front. Neurosci. 11 (2017).
Li, J. et al. Could cord blood cell therapy reduce preterm brain injury?. Front. Neurol. 5, 200 (2014).
Li, J. et al. Preterm white matter brain injury is prevented by early administration of umbilical cord blood cells. Exp. Neurol. 283, 179–187 (2016).
Li, J. et al. Term vs. preterm cord blood cells for the prevention of preterm brain injury. Pediatr. Res. (2017).
Zheng, G. et al. Mesenchymal stromal cells affect disease outcomes via macrophage polarization. Stem Cells Int. 2015, 989473 (2015).
Hass, R. et al. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. 9, 12 (2011).
Zhao, Q., Ren, H. & Han, Z. Mesenchymal stem cells: immunomodulatory capability and clinical potential in immune diseases. J. Cell. Immunother. 2, 3–20 (2016).
Berglund, A. K. et al. Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells. Stem Cell Res. Ther. 8, 288 (2017).
Kean, T. J. et al. MSCs: delivery routes and engraftment, cell-targeting strategies, and immune modulation. Stem Cells Int. 2013, 732742 (2013).
Paton, M. C. B. et al. Human umbilical cord blood therapy protects cerebral white matter from systemic LPS exposure in preterm fetal sheep. Dev. Neurosci. 40, 258–270 (2018).
Page, K. M. et al. Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality. Transfusion 54, 340–352 (2014).
Li, L. et al. Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. J. Inflamm. 9, 33 (2012).
Khwaja, O. & Volpe, J. J. Pathogenesis of cerebral white matter injury of prematurity. Arch. Dis. Childhood Fetal Neonatal Ed. 93, 2 (2008).
Melville, J. M. et al. Human amnion epithelial cells modulate the inflammatory response to ventilation in preterm lambs. PLoS ONE 12, e0173572 (2017).
Galinsky, R. et al. The consequences of chorioamnionitis: preterm birth and effects on development. J. Pregnancy 2013, 412831 (2013).
Wu, Y. W. & Colford, J. M. Chorioamnionitis as a risk factor for cerebral palsy. JAMA 284, 1417–1424 (2000).
Oh, K. J. et al. Twenty-four percent of patients with clinical chorioamnionitis in preterm gestations have no evidence of either culture-proven intraamniotic infection or intraamniotic inflammation. Am. J. Obstet. Gynecol. 216, 6 (2017).
March of Dimes et al. in Born too Soon: The Global Action Report on Preterm Birth (eds. Howson, C. P., Kinney, M. & Lawn, J. E.) (National Academy Press, 2012). Geneva: World Health Organization.
Cheong, J. L. et al. Association between moderate and late preterm birth and neurodevelopment and social-emotional development at age 2 years. JAMA Pediatr. 171, e164805 (2017).
McDonald, C. A. et al. Effects of umbilical cord blood cells, and subtypes, to reduce neuroinflammation following perinatal hypoxic–ischemic brain injury. J. Neuroinflamm. 15, 47 (2018).
Castillo-Melendez, M. et al. Stem cell therapy to protect and repair the developing brain: an overview of mechanisms of action of cord blood and amnion epithelial derived cells. Front. Neurosci. 7, 194 (2013).
Yoon, B. H. et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1β, and tumor necrosis factor-α), neonatal brain white matter lesions, and cerebral palsy. Am. J. Obstet. Gynecol. 177, 19–26 (1997).
Czeh, M., Gressens, P. & Kaindl, A. M. The yin and yang of microglia. Dev. Neurosci. 33, 199–209 (2011).
Kallapur, S. G. et al. IL-1 mediates pulmonary and systemic inflammatory responses to chorioamnionitis induced by lipopolysaccharide. Am. J. Respir. Crit. Care Med. 179, 955–961 (2009).
Shi, Y. et al. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol. 33, 136–143 (2012).
Kyurkchiev, D. et al. Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J. Stem Cells 6, 552–570 (2014).
Hannenhalli, S. & Kaestner, K. H. The evolution of Fox genes and their role in development and disease. Nat. Rev. Genet. 10, 233–240 (2009).
Suh, H. et al. Insulin-like growth factor 1 and 2 (IGF1, IGF-2) expression in human microglia: differential regulation by inflammatory mediators. J. Neuroinflamm. 10, 37 (2013).
Mason, J. L. et al. Insulin-like growth factor-1 inhibits matute oligodendrocyte apoptosis during primary demyelination. J. Neurosci. 20, 5703–5708 (2000).
Yao, D. et al. Insulin-like growth factor 1 treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune exephalomyelitis. Proc. Natl Acad. Sci. USA 92, 6190–6194 (1995).
Ullen, A. et al. Myeloperoxidase-derived oxidants induce blood–brain barrier dysfunction in vitro and in vivo. PLoS ONE 8, e64034 (2013).
Cotten, C. M. et al. Feasibility of autologous cord blood cells for infants with hypoxic–ischemic encephalopathy. J. Pediatr. 164, 973–979 e1 (2014).
Janowski, M. et al. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J. Cereb. Blood Flow Metab. 33, 921–927 (2013).
Li, J. et al. Preterm umbilical cord blood derived mesenchymal stem/stromal cells protect preterm white matter brain development against hypoxia–ischemia. Exp. Neurol. 308, 120–131 (2018).
Huang, L. et al. A randomized, placebo-controlled trial of human umbilical cord blood mesenchymal stem cell infusion for children with cerebral palsy. Cell Transplant. 27, 325–334 (2018).